| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Chaowen Jiang CEO | HKEX Exchange | G8918D108 CUSIP |
| Hong Kong Country | 655 Employees | - Last Dividend | 20 Jan 2015 Last Split | - IPO Date |
Kontafarma China Holdings Limited, originally founded in 1993 and headquartered in Wan Chai, Hong Kong, has evolved from its initial identity as Tongfang Kontafarma Holdings Limited, undergoing a name change in September 2022. Operating as an investment holding company, it has carved out a significant presence in the pharmaceutical industry, particularly focusing on the Mainland China market while also reaching Singapore, Taiwan, and international fronts. The company is recognized for its dual-segment operation, straddling the fields of Pharmaceutical Business and Fitness Business, hence embodying a unique blend of healthcare and wellness services. Kontafarma China Holdings Limited is a part of China Health Management Investment Limited, indicating a backing by substantial investment and management expertise in the health sector. Its business operations extend to manufacturing and selling prescription drugs, which include both chemical drugs and traditional Chinese medicines, underlining the company's roots and commitment to merging traditional and modern medicinal practices.
The range of products and services offered by Kontafarma China Holdings Limited is diverse, spanning across pharmaceutical and fitness domains: